Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("RENSHAW L")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 12 of 12

  • Page / 1
Export

Selection :

  • and

CIRCA-ANNUAL RHYTHMS OF PROLACTIN SECRETION IN EWES AND THE EFFECT OF PINEALECTOMYMUNRO CJ; MCNATTY KP; RENSHAW L et al.1980; J. ENDOCRINOL.; GBR; DA. 1980; VOL. 84; NO 1; PP. 83-89; BIBL. 26 REF.Article

Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITPMCMILLAN, R; TANI, P; MILLARD, F et al.Blood. 1987, Vol 70, Num 4, pp 1040-1045, issn 0006-4971Article

Effects of fulvestrant 750 mg in premenopausal women with oestrogen-receptor-positive primary breast cancerYOUNG, O. E; RENSHAW, L; MACASKILL, E. J et al.European journal of cancer (1990). 2008, Vol 44, Num 3, pp 391-399, issn 0959-8049, 9 p.Article

Proliferation, steroid receptors and clinical/pathological response in breast cancer treated with letrozoleMILLER, W. R; WHITE, S; DIXON, J. M et al.British journal of cancer. 2006, Vol 94, Num 7, pp 1051-1056, issn 0007-0920, 6 p.Article

The effects of neoadjuvant anastrozole (arimidex) on tumor volume in postmenopausal women with breast cancer: A randomized, double-blind, single-center studyDIXON, J. M; RENSHAW, L; BELLAMY, C et al.Clinical cancer research. 2000, Vol 6, Num 6, pp 2229-2235, issn 1078-0432Article

Anastrozole demonstrates clinical and biological effectiveness in oestrogen receptor-positive breast cancers, irrespective of the erbB2 statusDIXON, J. M; JACKSON, J; HILLS, M et al.European journal of cancer (1990). 2004, Vol 40, Num 18, pp 2742-2747, issn 0959-8049, 6 p.Article

How important is the scientific literature in guiding clinical decisions? The case of magnetic resonance imagingRAMSEY, S. D; HILLMAN, A. L; RENSHAW, L. R et al.International journal of technology assessment in health care. 1993, Vol 9, Num 2, pp 253-262, issn 0266-4623Article

A randomised study of the effects of letrozole and anastrozole on oestrogen receptor positive breast cancers in postmenopausal womenMURRAY, J; YOUNG, O. E; RENSHAW, L et al.Breast cancer research and treatment. 2009, Vol 114, Num 3, pp 495-501, issn 0167-6806, 7 p.Article

Src inhibitors in early breast cancer : a methodology, feasibility and variability studyJONES, R. J; YOUNG, O; DIXON, J. M et al.Breast cancer research and treatment. 2009, Vol 114, Num 2, pp 211-221, issn 0167-6806, 11 p.Article

Transplantation of T-lymphocyte-depleted bone marrow between HLA-mismatched individualsSPRUCE, W. E; MCWILLAN, R; MILLER, W et al.Transplantation. 1983, Vol 36, Num 4, pp 369-372, issn 0041-1337Article

The mammalian target of rapamycin inhibitor everolimus (RAD001) in early breast cancer: results of a pre-operative studyMACASKILL, E. J; BARTLETT, J. M. S; BARBER, M. D et al.Breast cancer research and treatment. 2011, Vol 128, Num 3, pp 725-734, issn 0167-6806, 10 p.Article

Neoadjuvant tamoxifen and aromatase inhibitors: comparisons and clinical outcomesDIXON, J. M; JACKSON, J; RENSHAW, L et al.Journal of steroid biochemistry and molecular biology. 2003, Vol 86, Num 3-5, pp 295-299, issn 0960-0760, 5 p.Conference Paper

  • Page / 1